Log In
CQMS
Make a Donation
Log In
Donate
  • Radiation Medicine
  • About Us
    • Our People
      • Our Board
      • Our Staff
    • Corporate Partners
    • Facility Alliance Members
    • President’s Message
    • Mission and Values
    • Cancer Research Careers
  • Our Research
    • Radiation Therapy Quality Assurance
    • All Trials
    • Open Trials – Recruiting
    • Open Trials – In Follow Up
    • Past Trials
    • Publications
  • Participants & Carers
    • Participant Stories
    • What is a Clinical Trial?
    • Radiation Therapy FAQs
  • Health & Research Professionals
    • Membership
    • New Proposals
    • Events
    • 2025 Annual Scientific Meeting
    • Grants
    • Scientific Committee
  • News & Resources
    • News
    • Glossary
    • Helpful Links
    • Reports
  • Support Us
    • Donate or fundraise for TROG
    • Ways to Donate
    • Trek4TROG Light-to-Light Challenge
    • TROG Ambassadors
  • Contact Us
  • Radiation Medicine
  • About Us
    • Our People
      • Our Board
      • Our Staff
    • Corporate Partners
    • Facility Alliance Members
    • President’s Message
    • Mission and Values
    • Cancer Research Careers
  • Our Research
    • Radiation Therapy Quality Assurance
    • All Trials
    • Open Trials – Recruiting
    • Open Trials – In Follow Up
    • Past Trials
    • Publications
  • Participants & Carers
    • Participant Stories
    • What is a Clinical Trial?
    • Radiation Therapy FAQs
  • Health & Research Professionals
    • Membership
    • New Proposals
    • Events
    • 2025 Annual Scientific Meeting
    • Grants
    • Scientific Committee
  • News & Resources
    • News
    • Glossary
    • Helpful Links
    • Reports
  • Support Us
    • Donate or fundraise for TROG
    • Ways to Donate
    • Trek4TROG Light-to-Light Challenge
    • TROG Ambassadors
  • Contact Us
  • Radiation Medicine
  • About Us
    • Our People
      • Our Board
      • Our Staff
    • Corporate Partners
    • Facility Alliance Members
    • President’s Message
    • Strategic Plan 2020-2023
    • Cancer Research Careers
  • Our Research
    • Radiation Therapy Quality Assurance
    • All Trials
    • Open Trials – Recruiting
    • Open Trials – In Follow Up
    • Upcoming Trials
    • Past Trials
    • Publications
  • Participants & Carers
    • Participant Stories
    • What is a Clinical Trial?
    • Radiation Therapy FAQs
  • Health & Research Professionals
    • Membership
    • New Proposals
    • Events
    • 2025 Annual Scientific Meeting
    • Grants
    • Scientific Committee
  • News & Resources
    • News
    • Glossary
    • Helpful Links
    • Reports
  • Support Us
    • Trek4TROG Light-to-Light Challenge
    • Ways to Donate
    • Donate or fundraise for TROG
    • TROG Ambassadors
  • Contact Us
  • Radiation Medicine
  • About Us
    • Our People
      • Our Board
      • Our Staff
    • Corporate Partners
    • Facility Alliance Members
    • President’s Message
    • Strategic Plan 2020-2023
    • Cancer Research Careers
  • Our Research
    • Radiation Therapy Quality Assurance
    • All Trials
    • Open Trials – Recruiting
    • Open Trials – In Follow Up
    • Upcoming Trials
    • Past Trials
    • Publications
  • Participants & Carers
    • Participant Stories
    • What is a Clinical Trial?
    • Radiation Therapy FAQs
  • Health & Research Professionals
    • Membership
    • New Proposals
    • Events
    • 2025 Annual Scientific Meeting
    • Grants
    • Scientific Committee
  • News & Resources
    • News
    • Glossary
    • Helpful Links
    • Reports
  • Support Us
    • Trek4TROG Light-to-Light Challenge
    • Ways to Donate
    • Donate or fundraise for TROG
    • TROG Ambassadors
  • Contact Us

TROG 98.02/EFC3344 – Head & Neck/Tirapazamine (Phase II)

    1. Home
    2. Trial
    3. TROG 98.02/EFC3344 – Head & Neck/Tirapazamine (Phase II)
  • By w.paterson
  • 15 August, 2021
  • 0 Comments
Completed
Head & Neck

Randomised Phase II Study of Two Different Strategies for Chemoradiotherapy in Advanced Squamous Cell Carcinoma of the Head and Neck

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)
Prev Post

TROG 98.03 – Prostate – Margin +ve Post-Prostatectomy

Next Post

TROG 98.01 – Rectal (Phase II)

Related Post

David, Jasmine and Susan Goode, re Kokoda Challenge to support TROG Cancer Research
27 May, 2025

Intrepid trekkers to take on Kokoda Challenge for TROG

LATEST NEWS: 27 May 2025 A team of five

Clinical Trials Day 2025 stand at Calvary Mater Newcastle
27 May, 2025

Clinical Trials Day celebrations help spread the work about TROG’s work

LATEST NEWS: 27 MAY 2025 TROG members and staff

Recent Posts

  • Intrepid trekkers to take on Kokoda Challenge for TROG
  • Clinical Trials Day celebrations help spread the work about TROG’s work
  • Newcastle’s world-class cancer research group marks Clinical Trials Day with major new trials
  • Grant for trial of new imaging technique to reduce radiation therapy side effects in lung cancer
  • Trial data-sharing made easier with HeSANDA initiative

Categories

  • Events 10
  • General 22
  • Journal 1
  • Participant Stories 12
  • Prostate Cancer 1
  • RAVES Trial 1
  • Trials 14
Register now

For over 30 years, Trans-Tasman Radiation Oncology Group has been dedicated to improving the way radiation medicine is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.

Facebook-f X-twitter Youtube Instagram

Quick Links

  • About Us
  • Our Research
  • Participants & Carers
  • Health & Research Professionals
  • News & Resources
  • Support Us
  • Contact Us

Legalities

  • Privacy Policy
  • Complaints & Feedback
  • Copyright Statement
  • Terms & Conditions
  • Cookie Warning
  • TROG Constitution

Latest News

Keep up to date with TROG news, subscribe to our community newsletter.

Subscribe

ABN:  45 132 672 292

TROG Cancer Research © 2025. All rights reserved

Website developed by the Marketing GP